In this webinar, Beverly Smet (SVP Global Accounts) and Pieterjan Dhondt (Associate Consultant) elaborated on some of the key trends in the Romanian specialty landscape, gathered from our Navigator365™ HCP Omnichannel affinity research. Key topics included: - How do Romanian HCPs compare to their EU5 colleagues? - How did COVID19 affect the reach & impact of your promotional & medical channels? - How satisfied are Romanian HCPs with pharma’s current digital offering? Find out more here: https://bit.ly/3yUnFsm

1. 18/07/2022
Proprietary and Confidential Information
© Across Health
1
Post-COVID Omnichannel HCP engagement
in Romania - key trends
Webinar – MONDAY 11/07

2. 18/07/2022
Proprietary and Confidential Information
© Across Health
2 Proprietary and Confidential Information 2
© Across Health

3. 18/07/2022
Proprietary and Confidential Information
© Across Health
3 Proprietary and Confidential Information 3
© Across Health
Biopharma needs to re-think the GTM model; COVID-19 has significantly
disrupted the traditional business model
Digital adoption is set to further accelerate post-COVID-19.
This represents an important opportunity for pharma companies to deliver
against HCPs' strong demand for omnichannel engagement
Post-COVID, HCPs want and expect to
receive pharma content via digital/mix of
channels1
OC Promo
preference
OC Education
preference
55% 69%
Source: Across Health Navigator™365 (Q4’ 21 EU4 + UK specialists – N= 6145)
Show me Navigator365™

4. 18/07/2022
Proprietary and Confidential Information
© Across Health
4 Proprietary and Confidential Information 4
© Across Health
Reach and impact of key digital channels is higher in Romania vs EU5
Owned promo – EU4+UK
Owned promo – ROM
Owned medical – EU4+UK
Owned medical – ROM
Paid– EU4+UK
Paid – ROM
2021 Q4: EU4 + UK, n = 2.230 - Romania, n = 267
o
wn
CME
eCME
scientific eNewsletter
scientific website
pharma call
rep/AM
email rep/AM
pharma eNewsletter
pharma website
remote rep/AM
local scientific meeting
MedEd
MSL
email MSL eMedEd
pharma webcast
remote MSL
0%
10%
20%
30%
40%
50%
60%
70%
80%
4,5 5,0 5,5 6,0 6,5 7,0 7,5 8,0 8,5
REACH%
IMPACT
PERFORMANCE MAP - ONCO UK
owned promo - offline EU4+UK owned promo - online EU4+UK owned medserv - offline EU4+UK owned medserv - online EU4+UK paid - EUK+UK paid - ROM owned promo ROM owned med rom
Pharma call
email rep/AM
pharma eNewsletter
pharma website
remote rep/AM
email MSL
rep/AM scientific eNewsletter
pharma webcast
eCME
MSL
local scientific meeting
scientific website
eMedEd
MedEd
remote MSL
CME
eCME
scientific eNewsletter
scientific website
pharma call
rep/AM
email rep/AM
pharma eNewsletter
pharma website
remote rep/AM
local scientific meeting
MedEd
MSL
email MSL eMedEd
pharma webcast
remote MSL
0%
10%
20%
30%
40%
50%
60%
70%
80%
4,5 5,0 5,5 6,0 6,5 7,0 7,5 8,0 8,5
REACH%
IMPACT
PERFORMANCE MAP - ONCO UK
owned promo - offline EU4+UK owned promo - online EU4+UK owned medserv - offline EU4+UK owned medserv - online EU4+UK paid - EUK+UK paid - ROM owned promo ROM owned med rom
Source: Specialists EU4+UK + Romania
Show me Navigator365™ Core

5. 18/07/2022
Proprietary and Confidential Information
© Across Health
5 Proprietary and Confidential Information 5
© Across Health
However, Romanian HCP engagement data suggests that pharma digital
supply has decreased again despite stable demand
2021 Q4: EU4 + UK, n = 3.098 - Romania, n = 267
Digital divide – Romanian specs – 2020 Digital divide – Romanian specs – 2021
24%
18%
85%
61%
59%
77%
+10 pp
+7 pp
34%
25%
82%
48%
46%
71%
Pharma supply
Pharma supply
Source: Specialists EU4+UK + Romania
Show me Navigator365™ Core

6. 18/07/2022
Proprietary and Confidential Information
© Across Health
6 Proprietary and Confidential Information 6
© Across Health
The Romanian market is mainly dominated by 2 HCPs archetypes
Relationship seekers and Independents
2021 Q4: EU4 + UK, n = 3.098 - Romania, n = 267
Source: Specialists EU4+UK + Romania
Show me Navigator365™ Core

7. 18/07/2022
Proprietary and Confidential Information
© Across Health
7 Proprietary and Confidential Information 7
© Across Health
“We are evolving into a more focused and innovative
biopharma company, and evolving the way we engage
with healthcare professionals in an increasingly digital
world. Now, physicians can have access to information
about medicines through a digital route rather than
through field forces, necessarily. If there is a disruption
and it helps, we don’t want to be the ones it will
happen to. We want to be the ones who will do it.”
Albert Bourla, CEO Pfizer
“Pharma companies must take the time to align our
strategies for adopting technology to the needs of
our business, address the cultural issues that prevent
us from harnessing the full power of digital tech in
our workforce and workplace, and avoid chasing the
next shiny object. As an industry, we need to have
the courage and preparedness to abandon our old
ways and begin building a fortified foundation of
strategic digitization.”
Paul Hudson, CEO Sanofi
“
“

8. 18/07/2022
Proprietary and Confidential Information
© Across Health
8 Proprietary and Confidential Information 8
© Across Health
Uniquely actionable research
for omnichannel customer engagement
& resource optimization
Over 5,000 biopharma users on the interactive data platform
85% find Navigator365™ (much) better than competition (MaturometerTM2022)

9. 18/07/2022
Proprietary and Confidential Information
© Across Health
9 Proprietary and Confidential Information 9
© Across Health
Want to know more? Then simply sign up for the remaining 2 webinars
2022 Webinar Series
1. Looking back & forward: Key trends in the HCP mix
2. Tips for your 2023 omnichannel budget planning
3. Omnichannel Launch Excellence: Medical & Commercial best practices
4. Omnichannel maturity: what’s the industry up to? (Maturometer 2022)
2022

10. 18/07/2022
Proprietary and Confidential Information
© Across Health
10
Watch the recorded webinar
and access the full deck here..
For more info, contact us!!

11. 18/07/2022
Proprietary and Confidential Information
© Across Health
11
Proprietary and confidential information
© Across Health 11
18/07/2022
https://www.across.health
Thank you!